New Castle, DE —December 5, 2024 — ABS Bio, Inc., a leader in biospecimen sourcing, cell culture services and biostorage for the global pharmaceutical and biotechnology industry, today announced a strategic refresh of its corporate brand identity.
The new brand identity elements reflect the company’s client-centric culture and are rooted in its legacy of deep scientific competence, quality and customer intimacy. Elements of the new branding include a new logo, color palette and messaging platform.
“After deep examination of our organizational and cultural DNA, we are excited to reintroduce ourselves to the market with a look and feel that reflects the strength of what we deliver for clients every day. While this will not change the way we operate in any way, it does energize our team and is a much clearer expression of what we represent to our clients,” commented Charlie Saller, Ph.D., Founder & CEO of ABS Bio.
The new logo and trade dress are effective immediately and the company will be integrating it into all branded materials over the coming months. An updated website reflecting the new branding and messaging is in development for launch in 2025.
Known in recent years as ABS Bio and also by its corporate name, Analytical Biological Services, Inc., the company will now go to market exclusively as ABS Bio.
LEARN MORE ABOUT ABS Bio's New Branding
About ABS Bio
Since its founding in 1990 by CEO Charlie Saller, Ph.D., ABS Bio has made research and discovery faster, easier, and more reliable for many pharmaceutical and biotech developers. With its suite of custom services — including biospecimen sourcing, cell culture services, and integrated biostorage — ABS Bio enables research scientists to focus on their core research objectives with the confidence that mission-critical support functions are being fulfilled promptly, accurately and according to client-specified quality requirements. Based in New Castle, DE, ABS Bio is distinguished by consistently high satisfaction ratings from clients ranging from large pharma to emerging biotech. For more information, visit ABSBio.com.
